Neos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
14 mars 2019 07h00 HE
|
Neos Therapeutics, Inc.
- New commercial strategy including optimized salesforce structure, new distribution network and focus on improving net margins expected to accelerate path to profitability – - Company to host...
Neos Therapeutics to Host Fourth Quarter and Year-End 2018 Financial and Operating Results Conference Call on March 14th, 2019
07 mars 2019 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 07, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the Cowen & Co. Annual Health Care Conference
06 mars 2019 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 06, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Announces Appointment of James Robinson to Board of Directors
30 janv. 2019 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Announces Settlement with Teva on Cotempla XR-ODT® Patent Litigation
26 déc. 2018 07h30 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Dec. 26, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Neos Therapeutics Reports Third Quarter 2018 Financial Results
09 nov. 2018 07h00 HE
|
Neos Therapeutics, Inc.
Company to host conference call today at 8:30am ET DALLAS and FORT WORTH, Texas, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a fully-integrated pharmaceutical...
Neos Therapeutics Licenses Pipeline Candidate for Treatment of Sialorrhea (Excessive Drooling)
23 oct. 2018 08h00 HE
|
Neos Therapeutics, Inc.
Approximately 1.4 Million Patients in the U.S. with Neurological Diseases Battle Sialorrhea with Burdensome and Complex Treatment Options Development Strategy Leverages Neos’ Modified-Release...
Neos Therapeutics to Present at the Wells Fargo Healthcare Conference
29 août 2018 07h30 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Neos Therapeutics Reports Second Quarter 2018 Financial Results
08 août 2018 07h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Neos Therapeutics to Host Second Quarter 2018 Financial Results Conference Call on August 8, 2018
01 août 2018 07h30 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...